Clinical Features and Treatment Outcomes of Eruptive Xanthomatosis: A Systematic Review

Abstract

Keywords

eruptive xanthomatosis eruptive xanthoma diabetes mellitus dyslipidemia obesity systematic review treatment outcomes

Get full access to this article

View all access options for this article.

References

Marogi

Ohiomoba

Stone

. Eruptive xanthomas: importance of recognition to reduce delay of effective triglyceride reduction. Am J Med. 2022;135(4):444-447. doi:10.1016/j.amjmed.2021.09.026

Ohtaki

Ashida

Matsuo

, et al Eruptive xanthomas as a marker for metabolic disorders: a specific form of xanthoma that reflects hypertriglyceridemia. Clin Case Rep. 2022;10(4):e05671. doi:10.1002/ccr3.5671

Zak

Zeman

Slaby

Vecka

. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(2):181-188. doi:10.5507/bp.2014.016

Kashif

Kumar

Khaja

. An unusual presentation of eruptive xanthoma: a case report and literature review. Medicine. 2016;95(37):e4866. doi:10.1097/MD.0000000000004866

Mija

Zhu

Mukovozov

. A systematic review of clinical features and treatment outcomes of Xanthoma disseminatum. J Cutan Med Surg. 2024;28(6):572-576. doi:10.1177/12034754241274356

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.20 MB

0.02 MB

0.04 MB